|
Market Closed -
Toronto S.E.
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 11.61 CAD | -0.77% |
|
+5.16% | +91.90% |
| 10-06 | Knight Therapeutics Inc. Receives Expedited Regulatory Approval Under ANVISA?s Rare Disease Pathway For NIKTIMVO® In Brazil | CI |
| 10-06 | Knight Therapeutics Strengthens Portfolio in Brazil | MT |
Chart: Technical Analysis
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| GUD | Delayed | |
OTC Markets
| KHTRF | Delayed | |
|
Deutsche Boerse AG
| 04K | Delayed | |
|
Tradegate
| 04K | Real-time | |
|
Boerse Muenchen
| 04K | Real-time | |
|
Börse Stuttgart
| 04K | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 11.7 | 11.7 | 12.45 |
| Spread/Res. | -0.77% | -0.77% | -6.75% |
| Spread/Supp. | +7.20% | +22.60% | +41.76% |
| Support | 10.83 | 9.47 | 8.19 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GUD Stock
- Charts Knight Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
